Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–48. https://doi.org/10.1016/s0140-6736(20)31288-5.

Article  CAS  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.

Article  PubMed  Google Scholar 

Suzuki S, Takahashi A, Ishikawa T, Akazawa K, Katai H, Isobe Y, et al. Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry. Gastric Cancer. 2021;24(3):545–66. https://doi.org/10.1007/s10120-021-01178-5.

Article  PubMed  Google Scholar 

Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19. https://doi.org/10.1007/s10120-016-0622-4.

Article  Google Scholar 

Van Cutsem E, Bang YJ, Feng-Yi F, Xu JM, Lee KW, Jiao SC, et al. HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer. 2015;18(3):476–84. https://doi.org/10.1007/s10120-014-0402-y.

Article  CAS  PubMed  Google Scholar 

Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–71. https://doi.org/10.1016/s0140-6736(17)31827-5.

Article  CAS  PubMed  Google Scholar 

Kanda M, Kasahara Y, Shimizu D, Miwa T, Umeda S, Sawaki K, et al. Amido-bridged nucleic acid-modified antisense oligonucleotides targeting SYT13 to treat peritoneal metastasis of gastric cancer. Mol Ther Nucleic Acids. 2020;22:791–802. https://doi.org/10.1016/j.omtn.2020.10.001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanda M, Shimizu D, Sawaki K, Nakamura S, Umeda S, Miwa T, et al. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer. Mol Cancer. 2020;19(1):131. https://doi.org/10.1186/s12943-020-01251-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SN, Kong SH, et al. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer. 2020;23(2):203–11. https://doi.org/10.1007/s10120-019-00995-z.

Article  PubMed  Google Scholar 

Kanda M, Shimizu D, Nakamura S, Sawaki K, Umeda S, Miwa T, et al. Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells. Oncogene. 2021;40(36):5495–504. https://doi.org/10.1038/s41388-021-01945-9.

Article  CAS  PubMed  Google Scholar 

Liu X, Cheng I, Plummer SJ, Suarez BK, Casey G, Catalona WJ, et al. Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35. Prostate. 2011;71(7):682–9. https://doi.org/10.1002/pros.21284.

Article  CAS  PubMed  Google Scholar 

Wang XW, Gao J, Xu YH, Xu JD, Fan ZX, Zhao XF, et al. Novel pattern recognition receptor protects shrimp by preventing bacterial colonization and promoting phagocytosis. J Immunol. 2017;198(8):3045–57. https://doi.org/10.4049/jimmunol.1602002.

Article  CAS  PubMed  Google Scholar 

Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88(3):323–31. https://doi.org/10.1016/s0092-8674(00)81871-1.

Article  CAS  PubMed  Google Scholar 

Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 1998;12(19):2973–83. https://doi.org/10.1101/gad.12.19.2973.

Article  CAS  PubMed  Google Scholar 

Hu W, Feng Z, Levine AJ. The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer. 2012;3(3–4):199–208. https://doi.org/10.1177/1947601912454734.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koul HK, Pal M, Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer. 2013;4(9–10):342–59. https://doi.org/10.1177/1947601913507951.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94(4):491–501. https://doi.org/10.1016/s0092-8674(00)81590-1.

Article  CAS  PubMed  Google Scholar 

Eblen ST. Extracellular-regulated kinases: signaling from Ras to ERK substrates to control biological outcomes. Adv Cancer Res. 2018;138:99–142. https://doi.org/10.1016/bs.acr.2018.02.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997–2007. https://doi.org/10.3892/etm.2020.8454.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolli R, Dawn B, Xuan YT. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med. 2003;13(2):72–9. https://doi.org/10.1016/s1050-1738(02)00230-x.

Article  CAS  PubMed  Google Scholar 

Vainchenker W, Constantinescu SN. JAK/STAT signaling in hematological malignancies. Oncogene. 2013;32(21):2601–13. https://doi.org/10.1038/onc.2012.347.

Article  CAS  PubMed  Google Scholar 

Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur J Med Chem. 2020;194:112260. https://doi.org/10.1016/j.ejmech.2020.112260.

Article  CAS  PubMed  Google Scholar 

Liu Y, Liu H, Luo X, Deng J, Pan Y, Liang H. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer. Tumour Biol. 2015;36(6):4377–86. https://doi.org/10.1007/s13277-015-3077-z.

Article  CAS  PubMed  Google Scholar 

Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell. 2011;22(8):1121–34. https://doi.org/10.1091/mbc.E10-10-0845.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang WK, Liao LD, Li LY, Xie YM, Xu XE, Zhao WJ, et al. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma. J Pathol. 2013;231(2):257–70. https://doi.org/10.1002/path.4236.

Article  CAS  PubMed  Google Scholar 

Yang M, Gu YY, Peng H, Zhao M, Wang J, Huang SK, et al. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. J Cancer Res Clin Oncol. 2015;141(6):1037–47. https://doi.org/10.1007/s00432-014-1865-2.

Article  CAS  PubMed  Google Scholar 

Wei XD, Liu X, Liu HM, He X, Zhuang H, Tang YP, et al. BRCA1-associated protein induced proliferation and migration of gastric cancer cells through MAPK pathway. Surg Oncol. 2020;35:191–9. https://doi.org/10.1016/j.suronc.2020.08.007.

Article  PubMed  Google Scholar 

Jia SQ, Lu JJ, Qu TT, Feng Y, Wang XH, Liu CX, et al. MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer. Chin J Cancer Res. 2017;29(1):25–35. https://doi.org/10.21147/j.issn.1000-9604.2017.01.04.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi Y, Sun HH. Down-regulation of lncRNA LINC00152 suppresses gastric cancer cell migration and invasion through inhibition of the ERK/MAPK signaling pathway. Onco Targets Ther. 2020;13:2115–24. https://doi.org/10.2147/ott.s217452.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maeda M, Taniguchi H, Sekiguchi S, Katai H, Kushima R. Adenosquamous cell carcinoma of the stomach-a clinicopathologic analysis of 23 cases. Stomach Intestine (abstract in English). 2010;45(12):1959–66. https://doi.org/10.11477/mf.1403102164.

Article  Google Scholar